Mason Street Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Mason Street Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,418	Closed	-$141K	–	1525
2015 Q2	$141K	Buy	3,418 +135	+4%	+$4.84K	﹤0.01%	1220
2015 Q1	$116K	Buy	3,283 +108	+3%	+$3.65K	﹤0.01%	1259
2014 Q4	$102K	Buy	3,175 +96	+3%	+$2.78K	﹤0.01%	1682
2014 Q3	$86K	Sell	3,079 -22	-0.7%	-$670	﹤0.01%	1707
2014 Q2	$94K	Buy	3,101 +89	+3%	+$2.46K	﹤0.01%	1685
2014 Q1	$83K	Sell	3,012 -905	-23%	-$23.7K	﹤0.01%	1698
2013 Q4	$100K	Buy	3,917 +296	+8%	+$9.12K	﹤0.01%	1702
2013 Q3	$108K	Buy	3,621 +248	+7%	+$6.9K	﹤0.01%	1502
2013 Q2	$97K	Buy	+3,373	New	+$92.9K	﹤0.01%	1446

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Mason Street Advisors's BRLI Position: Q3 2015 in Review

Mason Street Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 3,418 shares — an estimated $141K sold.

Mason Street Advisors first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $141K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Mason Street Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Mason Street Advisors sold 3,418 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $141K.
Mason Street Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Mason Street Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $141K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Mason Street Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.